PreCancer Atlas: Present and Future

Author:

Srivastava Sudhir1ORCID,Wagner Paul D.1ORCID,Hughes Shannon K.2ORCID,Ghosh Sharmistha2ORCID

Affiliation:

1. 1Division of Cancer Prevention, National Cancer Institute, NIH, Rockville, Maryland.

2. 2Division of Cancer Biology, National Cancer Institute, NIH, Rockville, Maryland.

Abstract

Abstract Precancer atlases have the potential to revolutionize how we think about the topographic and morphologic structures of precancerous lesions in relation to cellular, molecular, genetic, and pathophysiologic states. This mini review uses the Human Tumor Atlas Network (HTAN), established by the National Cancer Institute (NCI), to illustrate the construction of cellular and molecular three-dimensional atlases of human cancers as they evolve from precancerous lesions to advanced disease. We describe the collaborative nature of the network and the research to determine how and when premalignant lesions progress to invasive cancer, regress or obtain a state of equilibrium. We have attempted to highlight progress made by HTAN in building precancer atlases and discuss possible future directions. It is hoped that the lessons from our experience with HTAN will help other investigators engaged in the construction of precancer atlases to crystallize their thoughts on logistics, rationale, and implementation.

Funder

National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Reference15 articles.

1. Precursors in cancer epidemiology: aligning definition and function;Wacholder;Cancer Epidemiol Biomarkers Prev,2013

2. Behavior of moderate cervical dysplasia during long-term follow-up;Nasiell;Obstet Gynecol,1983

3. Persistence of bronchial dysplasia is associated with development of invasive squamous cell carcinoma;Merrick;Cancer Prev Res (Phila),2016

4. The case for a Pre-Cancer Genome Atlas (PCGA);Campbell;Cancer Prev Res (Phila),2016

5. National Cancer Institute's HTAN Implementation Team. The making of a precancer atlas: promises, challenges, and opportunities;Srivastava;Trends Cancer,2018

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-01

2. Biomarkers in Cancer Screening;Hematology/Oncology Clinics of North America;2024-08

3. Skin Cancer Precursors;Hematology/Oncology Clinics of North America;2024-08

4. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours;Nature Reviews Cancer;2024-06-12

5. Advancing Cancer Interception;Cancer Discovery;2024-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3